Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Amortizatization of Intangibles (2022 - 2025)

Editas Medicine (EDIT) has disclosed Amortizatization of Intangibles for 4 consecutive years, with $62000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Amortizatization of Intangibles fell 95.32% to $62000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $1.8 million, a 74.79% decrease, with the full-year FY2024 number at $5.8 million, up 20.07% from a year prior.
  • Amortizatization of Intangibles was $62000.0 for Q3 2025 at Editas Medicine, down from $257000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $2.1 million in Q4 2023 to a low of $62000.0 in Q3 2025.
  • A 4-year average of $1.0 million and a median of $824500.0 in 2023 define the central range for Amortizatization of Intangibles.
  • Peak YoY movement for Amortizatization of Intangibles: skyrocketed 322.29% in 2023, then tumbled 95.32% in 2025.
  • Editas Medicine's Amortizatization of Intangibles stood at $498000.0 in 2022, then surged by 322.29% to $2.1 million in 2023, then crashed by 58.68% to $869000.0 in 2024, then crashed by 92.87% to $62000.0 in 2025.
  • Per Business Quant, the three most recent readings for EDIT's Amortizatization of Intangibles are $62000.0 (Q3 2025), $257000.0 (Q2 2025), and $583000.0 (Q1 2025).